The short version
- Why people research itMitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- What the evidence isThe human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
- What to watchCoughing blood or rust-colored sputum.
How Bronchogen works
Short peptide bioregulator targeting bronchopulmonary tissue — proposed to support respiratory-tissue gene expression.
Bronchogen is four amino acids long, and the first thing to know about it is that the published record does not agree on their order. This site's catalog and the originating group's own 2021 gene-expression review write it Ala-Glu-Asp-Leu.
The chemistry that follows is the same either way. Glutamate and aspartate each carry a side-chain carboxyl; add the C-terminal carboxyl, subtract the protonated N-terminal amine, and the computed net charge at blood pH is about −2.06, with an isoelectric point of 3.55. At the pH of plasma this molecule is a dianion, and a 446 Da dianion does not cross a lipid membrane by diffusion in either direction.
- Injectable
On the goal map: Liver, kidney, gut & lung (Organ-specific bioregulation)
Research on Bronchogen5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
The human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
Correlative data
Sold for respiratory tissue support, typically in oral courses and often paired with Chonluten or Taxorest. Interest rose considerably after 2020 for obvious reasons, without any evidence arriving to match it.
How the mechanism reads
Ala-Glu-Asp-Leu — a defined tetrapeptide targeting bronchopulmonary tissue.
MechanisticThe shared claim across the Khavinson series: peptides this short are proposed to enter the cell nucleus and bind promoter regions of DNA, shifting tissue-specific gene expression.
MechanisticLung is a plausible target and a hard one to read. Respiratory function is measurable with cheap spirometry, so a controlled test would be straightforward — the absence of one after decades of sale is the relevant fact.
Mechanistic
Sources
- Zakutskiĭ AN, et al. The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats. Advances in Gerontology 2006 · PMID 17152728
- Fedoreyeva LI, et al. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. Biochemistry (Moscow) 2011;76(11):1210–1219 · PMID 22117547
- Monaselidze JR, Khavinson VKh, Gorgoshidze MZ, Khachidze DG, Lomidze EM, Jokhadze TA, Lezhava TA. Effect of the peptide bronchogen (Ala-Asp-Glu-Leu) on DNA thermostability. Bulletin of Experimental Biology and Medicine 2011;150(3):375–377 · PMID 21240358
- Kuzubova NA, Lebedeva ES, Dvorakovskaya IV, Surkova EA, Platonova IS, Titova ON. Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Rats with Obstructive Lung Pathology. Bulletin of Experimental Biology and Medicine 2015;159(5):685–688 · PMID 26468022
- Khavinson VKh, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules 2021;26(22):7053 · PMID 34834147
- Khavinson V, Linkova N, Kozhevnikova E, Dyatlova A, Petukhov M. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. International Journal of Molecular Sciences 2022;23(14):7733 · PMID 35887081
- Khavinson VK, Linkova NS, Rudskoy AI, Petukhov MG. Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters. Biomolecules 2023;13(3):552 · PMID 36979488
Bronchogen safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Coughing up blood, unexplained weight loss or a cough lasting weeks that has not been evaluated.
- Smoker with a new respiratory symptom.
- Active lung cancer, as the peptide claims to shift bronchial cell gene expression.
- Pregnancy, as bioregulator peptides were never studied in it.
What’s expected
- Nothing immediate; the claim is slow normalization of bronchial epithelial gene expression.
- Occasional mild gut upset.
- Animal and cell work only, with scant human data.
Watch for
- Coughing blood or rust-colored sputum.
- New breathlessness at rest or on light effort.
- Fever with chest pain.
Labs that tell you it’s working
- hs-CRP: an airway inflammation signal if the effect is real.
- ESR: slow-moving inflammation that persists with chronic lung disease.
- Complete Blood Count: infection and eosinophils in allergic airway disease.
Ala-Asp-Glu-Leu bioregulator proposed to act on bronchopulmonary cell gene expression; the main risk is delay in diagnosing real lung disease. PMID 21240358 PMID 17152728
Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Bronchogen FAQ4 common questions
- Is Bronchogen approved for human use?
- No. Bronchogen is a research compound.
- What is Bronchogen researched for?
- Mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- Which labs show whether it's doing anything?
- hs-CRP; ESR; Complete Blood Count: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Bronchogen: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.




